Azenta EPS - Earnings per Share 2011-2025 | AZTA
| Azenta Annual EPS | |
|---|---|
| 2024 | $-3.09 |
| 2023 | $-0.22 |
| 2022 | $28.48 |
| 2021 | $1.49 |
| 2020 | $0.88 |
| 2019 | $6.04 |
| 2018 | $1.64 |
| 2017 | $0.89 |
| 2016 | $-1.01 |
| 2015 | $0.21 |
| 2014 | $0.46 |
| 2013 | $-0.03 |
| 2012 | $2.08 |
| 2011 | $2.01 |
| Azenta Quarterly EPS | |
|---|---|
| 2025-06-30 | $-1.15 |
| 2025-03-31 | $-0.88 |
| 2024-12-31 | $-0.29 |
| 2024-09-30 | $-0.22 |
| 2024-06-30 | $-0.12 |
| 2024-03-31 | $-2.47 |
| 2023-12-31 | $-0.28 |
| 2023-09-30 | $0.02 |
| 2023-06-30 | $-0.02 |
| 2023-03-31 | $-0.07 |
| 2022-12-31 | $-0.15 |
| 2022-09-30 | $-0.25 |
| 2022-06-30 | $-0.13 |
| 2022-03-31 | $28.28 |
| 2021-12-31 | $0.58 |
| 2021-09-30 | $0.29 |
| 2021-06-30 | $0.53 |
| 2021-03-31 | $0.32 |
| 2020-12-31 | $0.35 |
| 2020-09-30 | $0.39 |
| 2020-06-30 | $0.19 |
| 2020-03-31 | $0.12 |
| 2019-12-31 | $0.18 |
| 2019-09-30 | $5.69 |
| 2019-06-30 | $0.10 |
| 2019-03-31 | $0.05 |
| 2018-12-31 | $0.20 |
| 2018-09-30 | $0.14 |
| 2018-06-30 | $0.32 |
| 2018-03-31 | $0.95 |
| 2017-12-31 | $0.23 |
| 2017-09-30 | $0.24 |
| 2017-06-30 | $0.25 |
| 2017-03-31 | $0.20 |
| 2016-12-31 | $0.20 |
| 2016-09-30 | $0.16 |
| 2016-06-30 | $0.12 |
| 2016-03-31 | $-1.22 |
| 2015-12-31 | $-0.07 |
| 2015-09-30 | $0.10 |
| 2015-06-30 | $0.11 |
| 2015-03-31 | $0.04 |
| 2014-12-31 | $-0.04 |
| 2014-09-30 | $0.00 |
| 2014-06-30 | $0.36 |
| 2014-03-31 | $0.05 |
| 2013-12-31 | $0.05 |
| 2013-09-30 | $0.10 |
| 2013-06-30 | $0.02 |
| 2013-03-31 | $-0.01 |
| 2012-12-31 | $-0.14 |
| 2012-09-30 | $1.77 |
| 2012-06-30 | $0.12 |
| 2012-03-31 | $0.15 |
| 2011-12-31 | $0.04 |
| 2011-09-30 | $0.21 |
| 2011-06-30 | $1.03 |
| 2011-03-31 | $0.41 |
| 2010-12-31 | $0.36 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $1.346B | $0.656B |
| Azenta Inc. is a provider of life sciences solutions. The company provides reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and advanced cell therapies for the pharmaceutical, biotech, academic and healthcare institutions. Azenta Inc., formerly known as Brooks Automation Inc., is based in CHELMSFORD, Mass. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $48.330B | 58.97 |
| Tempus AI (TEM) | United States | $12.432B | 0.00 |
| Doximity (DOCS) | United States | $10.168B | 42.09 |
| Hims & Hers Health (HIMS) | United States | $9.274B | 75.98 |
| IRhythm Technologies (IRTC) | United States | $5.625B | 0.00 |
| Hinge Health (HNGE) | United States | $3.490B | 0.00 |
| Privia Health (PRVA) | United States | $2.876B | 180.23 |
| Heartflow (HTFL) | United States | $2.715B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $2.376B | 39.32 |
| 10x Genomics (TXG) | United States | $1.898B | 0.00 |
| Enovis (ENOV) | United States | $1.604B | 8.43 |
| Omnicell (OMCL) | United States | $1.601B | 32.73 |
| Clover Health Investments (CLOV) | United States | $1.368B | 0.00 |
| Phreesia (PHR) | United States | $1.319B | 0.00 |
| Schrodinger (SDGR) | United States | $1.309B | 0.00 |
| Claritev (CTEV) | United States | $1.141B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.807B | 0.00 |
| Evolent Health (EVH) | United States | $0.583B | 0.00 |
| Talkspace (TALK) | United States | $0.571B | 113.67 |
| Butterfly Network (BFLY) | United States | $0.561B | 0.00 |
| Veradigm (MDRX) | United States | $0.523B | 0.00 |
| Standard BioTools (LAB) | United States | $0.435B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.396B | 0.00 |
| Carlsmed (CARL) | United States | $0.363B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.295B | 0.00 |
| TruBridge (TBRG) | United States | $0.292B | 13.39 |
| CapsoVision (CV) | United States | $0.221B | 0.00 |
| Outset Medical (OM) | United States | $0.214B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.212B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.199B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.180B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.179B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.167B | 0.00 |
| CareCloud (CCLD) | United States | $0.147B | 8.06 |
| EUDA Health Holdings (EUDA) | Singapore | $0.127B | 0.00 |
| Pulmonx (LUNG) | United States | $0.078B | 0.00 |
| NetraMark Holdings (AINMF) | Canada | $0.075B | 0.00 |
| American Well (AMWL) | United States | $0.068B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.057B | 0.00 |
| HeartBeam (BEAT) | United States | $0.057B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.040B | 0.00 |
| 111 (YI) | China | $0.036B | 0.00 |
| Precipio (PRPO) | United States | $0.032B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.026B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.022B | 0.00 |
| Zhongchao (ZCMD) | China | $0.018B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.016B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.011B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.009B | 0.00 |
| PROFUSA (PFSA) | United States | $0.008B | 0.00 |
| HeartSciences (HSCS) | United States | $0.007B | 0.00 |
| Movano (MOVE) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.002B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.001B | 0.00 |